Literature DB >> 14597102

Langerhans cells beta 2-adrenoceptors: role in migration, cytokine production, Th priming and contact hypersensitivity.

Georges J M Maestroni1, Paola Mazzola.   

Abstract

We showed that norepinephrine (NE) hampers IL-12 and stimulates IL-10 production via adrenoceptors (ARs) in bone marrow-derived dendritic cells (BMDC) influencing their Th priming ability. Others have shown that Langerhans cells (LC) express mRNA for beta1-, beta2- and alpha1(A)-(ARs) and that catecholamines may inhibit the antigen-presenting capability via beta2-ARs. Here, we show that also BMDC express mRNA for beta1-, beta2-, alpha2(A)- and alpha2(C)-ARs. Inhibition of IL-12 is mediated by both beta2- and alpha2(A)-ARs, while stimulation of IL-10 by beta2-ARs only. In addition, LC migration, the contact hypersensitivity response (CHS) and production of IFN-gamma and IL-2 in draining lymph node cells is increased in mice treated topically with the beta2-AR antagonist ICI 118,551 during FITC sensitization. Activation of beta2-ARs in BMDC before adoptive transfer could reduce both migration and CHS response to FITC. Finally, preincubation of BMDC with LPS in presence of the specific beta2-AR agonist salbutamol impaired their chemotactic response to CCL19 and CCL21 and this effect was neutralized by anti-IL-10 mAb. We suggest that the physiological activation of beta2-ARs in DC (LC) results in stimulation of IL-10 which in turn restrains DC (LC) migration influencing antigen presentation and the consequent CHS response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14597102     DOI: 10.1016/j.jneuroim.2003.08.039

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  32 in total

Review 1.  G protein-coupled receptors as therapeutic targets for multiple sclerosis.

Authors:  Changsheng Du; Xin Xie
Journal:  Cell Res       Date:  2012-06-05       Impact factor: 25.617

Review 2.  Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens.

Authors:  Esther M Sternberg
Journal:  Nat Rev Immunol       Date:  2006-04       Impact factor: 53.106

3.  Murine hematopoietic stem cells and progenitors express adrenergic receptors.

Authors:  Kuzhali Muthu; Sivaraman Iyer; L-K He; Andrea Szilagyi; Richard L Gamelli; Ravi Shankar; Stephen B Jones
Journal:  J Neuroimmunol       Date:  2007-04-10       Impact factor: 3.478

Review 4.  Stress-induced remodeling of lymphoid innervation.

Authors:  Erica K Sloan; John P Capitanio; Steve W Cole
Journal:  Brain Behav Immun       Date:  2007-08-13       Impact factor: 7.217

Review 5.  Neural regulation of hematopoiesis, inflammation, and cancer.

Authors:  Maher Hanoun; Maria Maryanovich; Anna Arnal-Estapé; Paul S Frenette
Journal:  Neuron       Date:  2015-04-22       Impact factor: 17.173

Review 6.  Neuroimmune interactions: dendritic cell modulation by the sympathetic nervous system.

Authors:  Maisa C Takenaka; Marcia G Guereschi; Alexandre S Basso
Journal:  Semin Immunopathol       Date:  2016-10-31       Impact factor: 9.623

7.  Epinephrine-primed murine bone marrow-derived dendritic cells facilitate production of IL-17A and IL-4 but not IFN-γ by CD4+ T cells.

Authors:  Byung-Jin Kim; Harlan P Jones
Journal:  Brain Behav Immun       Date:  2010-05-31       Impact factor: 7.217

8.  β2-adrenergic stimulation of dendritic cells favors IL-10 secretion by CD4+ T cells.

Authors:  Julie Hervé; Karine Haurogné; Elodie Bacou; Sylvie Pogu; Marie Allard; Grégoire Mignot; Jean-Marie Bach; Blandine Lieubeau
Journal:  Immunol Res       Date:  2017-12       Impact factor: 2.829

9.  Upregulation of phagocyte-derived catecholamines augments the acute inflammatory response.

Authors:  Michael A Flierl; Daniel Rittirsch; Brian A Nadeau; J Vidya Sarma; Danielle E Day; Alex B Lentsch; Markus S Huber-Lang; Peter A Ward
Journal:  PLoS One       Date:  2009-02-12       Impact factor: 3.240

10.  Sympathetic nervous system control of anti-influenza CD8+ T cell responses.

Authors:  Kristie M Grebe; Heather D Hickman; Kari R Irvine; Kazuyo Takeda; Jack R Bennink; Jonathan W Yewdell
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.